In its trade deals with Southeast Asian countries, the Trump administration included “poison pill” provisions designed to curb Chinese influence in the region. The provisions, part of new agreements inked with Malaysia and Cambodia last week, give the U.S. the right to cancel the deals should either country sign a competing pact that endangers core U.S. interests or security. Trade commentators say the sweeping nature of the clauses effectively forces smaller countries that trade with China to choose sides and could alter the course of future U.S. trade diplomacy in Southeast Asia. Economists say that the provisions could push Southeast Asian exporters to reconsider their supply chain choices. Firms that depend on Chinese inputs could face increased compliance costs or even be excluded from the U.S. market. This transformation could alter investment and production patterns in the region. Simon Evenett, professor of strategy and geopolitics at Switzerland’s IMD Business School, has defended the new strategy: “This is the U.S. protecting its market access strength through these agreements to try and reshape the ‘factory Asia’ that has developed over recent decades.”  Lowe says US agreements with Malaysia and Cambodia were tactical  Evenett noted that the expansive clauses vest termination powers squarely in U.S. hands and provide Washington with new leverage in Southeast Asia. The Malaysia deal further binds the country to uphold U.S. sanctions and economic policies. He added, “Ultimately, poison pill provisions transform trade agreements from purely commercial instruments into tools for managing partner countries’ broader foreign economic policy orientation.” He also argues that the U.S.-Mexico-Canada Agreement, as signed in 2020, provides a partial precedent – similar to that of other Southeast Asian pacts, except that its stipulations are narrowly defined and legally enforceable. According to trade advisor Sam Lowe at Flint Global, the Malaysia and Cambodia deals with the U.S. were more strategic moves than substantive economic commitments. He admitted that these adjustments were part of an effort to correct the pitfalls brought about by President Trump’s trade initiatives, noting that they would only be effective until conditions changed. Maria Demertzis, whose position as head of the Conference Board’s economic strategy centre, also called the “poison pill” clauses, another sign of political degradation into deeper divisions and less multilateral cooperation. Critics in Malaysia say the deal weakens the country’s autonomy The “poison pill” provisions add to U.S. plans to impose 40% tariffs on Chinese-made products rerouted via Southeast Asian ports. Trade analysts say future U.S. reciprocal tariff deals with Southeast Asian countries — particularly Thailand and Vietnam — could reveal whether Washington intends to extend the use of poison pill clauses. In Malaysia, however, the trade pact has met with fierce criticism. Many of its opponents argue that it undermines national sovereignty and contravenes Malaysia’s long-standing policy of neutrality. Nonetheless, the country’s trade ministry has emphasised that the U.S. cannot force its hand, noting that the terms only require talks or consultations before decisions are implemented. U.S. trade negotiations with much of Southeast Asia were slow to start, but Trump’s summer meetings with Cambodian and Thai leaders over their border conflict gave the talks fresh momentum. However, political changes in Bangkok have slowed progress on a U.S.-Thailand trade deal, and talks with Vietnam are proving equally complicated. Don’t just read crypto news. Understand it. Subscribe to our newsletter. It's free.In its trade deals with Southeast Asian countries, the Trump administration included “poison pill” provisions designed to curb Chinese influence in the region. The provisions, part of new agreements inked with Malaysia and Cambodia last week, give the U.S. the right to cancel the deals should either country sign a competing pact that endangers core U.S. interests or security. Trade commentators say the sweeping nature of the clauses effectively forces smaller countries that trade with China to choose sides and could alter the course of future U.S. trade diplomacy in Southeast Asia. Economists say that the provisions could push Southeast Asian exporters to reconsider their supply chain choices. Firms that depend on Chinese inputs could face increased compliance costs or even be excluded from the U.S. market. This transformation could alter investment and production patterns in the region. Simon Evenett, professor of strategy and geopolitics at Switzerland’s IMD Business School, has defended the new strategy: “This is the U.S. protecting its market access strength through these agreements to try and reshape the ‘factory Asia’ that has developed over recent decades.”  Lowe says US agreements with Malaysia and Cambodia were tactical  Evenett noted that the expansive clauses vest termination powers squarely in U.S. hands and provide Washington with new leverage in Southeast Asia. The Malaysia deal further binds the country to uphold U.S. sanctions and economic policies. He added, “Ultimately, poison pill provisions transform trade agreements from purely commercial instruments into tools for managing partner countries’ broader foreign economic policy orientation.” He also argues that the U.S.-Mexico-Canada Agreement, as signed in 2020, provides a partial precedent – similar to that of other Southeast Asian pacts, except that its stipulations are narrowly defined and legally enforceable. According to trade advisor Sam Lowe at Flint Global, the Malaysia and Cambodia deals with the U.S. were more strategic moves than substantive economic commitments. He admitted that these adjustments were part of an effort to correct the pitfalls brought about by President Trump’s trade initiatives, noting that they would only be effective until conditions changed. Maria Demertzis, whose position as head of the Conference Board’s economic strategy centre, also called the “poison pill” clauses, another sign of political degradation into deeper divisions and less multilateral cooperation. Critics in Malaysia say the deal weakens the country’s autonomy The “poison pill” provisions add to U.S. plans to impose 40% tariffs on Chinese-made products rerouted via Southeast Asian ports. Trade analysts say future U.S. reciprocal tariff deals with Southeast Asian countries — particularly Thailand and Vietnam — could reveal whether Washington intends to extend the use of poison pill clauses. In Malaysia, however, the trade pact has met with fierce criticism. Many of its opponents argue that it undermines national sovereignty and contravenes Malaysia’s long-standing policy of neutrality. Nonetheless, the country’s trade ministry has emphasised that the U.S. cannot force its hand, noting that the terms only require talks or consultations before decisions are implemented. U.S. trade negotiations with much of Southeast Asia were slow to start, but Trump’s summer meetings with Cambodian and Thai leaders over their border conflict gave the talks fresh momentum. However, political changes in Bangkok have slowed progress on a U.S.-Thailand trade deal, and talks with Vietnam are proving equally complicated. Don’t just read crypto news. Understand it. Subscribe to our newsletter. It's free.

Trump's Southeast Asia deals target China’s diplomatic interests in the region

2025/11/06 19:01
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

In its trade deals with Southeast Asian countries, the Trump administration included “poison pill” provisions designed to curb Chinese influence in the region.

The provisions, part of new agreements inked with Malaysia and Cambodia last week, give the U.S. the right to cancel the deals should either country sign a competing pact that endangers core U.S. interests or security.

Trade commentators say the sweeping nature of the clauses effectively forces smaller countries that trade with China to choose sides and could alter the course of future U.S. trade diplomacy in Southeast Asia.

Economists say that the provisions could push Southeast Asian exporters to reconsider their supply chain choices. Firms that depend on Chinese inputs could face increased compliance costs or even be excluded from the U.S. market. This transformation could alter investment and production patterns in the region.

Simon Evenett, professor of strategy and geopolitics at Switzerland’s IMD Business School, has defended the new strategy: “This is the U.S. protecting its market access strength through these agreements to try and reshape the ‘factory Asia’ that has developed over recent decades.” 

Lowe says US agreements with Malaysia and Cambodia were tactical 

Evenett noted that the expansive clauses vest termination powers squarely in U.S. hands and provide Washington with new leverage in Southeast Asia. The Malaysia deal further binds the country to uphold U.S. sanctions and economic policies.

He added, “Ultimately, poison pill provisions transform trade agreements from purely commercial instruments into tools for managing partner countries’ broader foreign economic policy orientation.” He also argues that the U.S.-Mexico-Canada Agreement, as signed in 2020, provides a partial precedent – similar to that of other Southeast Asian pacts, except that its stipulations are narrowly defined and legally enforceable.

According to trade advisor Sam Lowe at Flint Global, the Malaysia and Cambodia deals with the U.S. were more strategic moves than substantive economic commitments. He admitted that these adjustments were part of an effort to correct the pitfalls brought about by President Trump’s trade initiatives, noting that they would only be effective until conditions changed.

Maria Demertzis, whose position as head of the Conference Board’s economic strategy centre, also called the “poison pill” clauses, another sign of political degradation into deeper divisions and less multilateral cooperation.

Critics in Malaysia say the deal weakens the country’s autonomy

The “poison pill” provisions add to U.S. plans to impose 40% tariffs on Chinese-made products rerouted via Southeast Asian ports. Trade analysts say future U.S. reciprocal tariff deals with Southeast Asian countries — particularly Thailand and Vietnam — could reveal whether Washington intends to extend the use of poison pill clauses.

In Malaysia, however, the trade pact has met with fierce criticism. Many of its opponents argue that it undermines national sovereignty and contravenes Malaysia’s long-standing policy of neutrality.

Nonetheless, the country’s trade ministry has emphasised that the U.S. cannot force its hand, noting that the terms only require talks or consultations before decisions are implemented.

U.S. trade negotiations with much of Southeast Asia were slow to start, but Trump’s summer meetings with Cambodian and Thai leaders over their border conflict gave the talks fresh momentum. However, political changes in Bangkok have slowed progress on a U.S.-Thailand trade deal, and talks with Vietnam are proving equally complicated.

Don’t just read crypto news. Understand it. Subscribe to our newsletter. It's free.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

BitcoinWorld Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience ZURICH, March 2025 – The Swiss National Bank faces mounting
Share
bitcoinworld2026/03/16 23:10
Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26